Clinical Trials Logo

Clinical Trial Summary

Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.

Clinical Trial Description

The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by thermal ablation. Informed consent was signed by each participant. Just after treatment, they were inquired about the level of pain during the procedure, and their level of satisfaction with the treatment. They were followed-up at 6 weeks for any complication and re-assessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05211271
Study type Interventional
Source International Agency for Research on Cancer
Status Completed
Phase N/A
Start date October 1, 2018
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT00702208 - Feasibility of Delphi Screener for Cervical Cytology Phase 2
Completed NCT02253719 - Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia N/A
Not yet recruiting NCT02908607 - Thermal Imaging for Evaluation of the Cervix Phase 1/Phase 2
Withdrawn NCT00503919 - Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device Phase 1
Terminated NCT00342173 - Costa Rican Natural History Study of HPV and Cervical Neoplasia
Completed NCT00435214 - Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Completed NCT01086709 - Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Completed NCT00766701 - Spectroscopic Evaluation of Cervical Neoplasia N/A
Completed NCT00456807 - Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years Phase 3